• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® MULTILENGTH URETERAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® MULTILENGTH URETERAL STENT Back to Search Results
Catalog Number 788600
Device Problems Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Shock (2072); Reaction (2414)
Event Date 10/08/2019
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.The device was not returned.
 
Event Description
It was reported that allergic symptoms were observed on the patient a short while after the stent was inserted.The patient recovered after the treatment.Per additional information received by the ibc representative on 16-oct-19, the patient allergies were unknown and the course of treatment was unknown.
 
Event Description
It was reported that allergic symptoms were observed on the patient a short while after the stent was inserted.The patient recovered after the treatment.Per additional information received by the ibc representative on 16-oct-19, the patient allergies were unknown and the course of treatment was unknown.
 
Manufacturer Narrative
The device was not returned for evaluation.A potential root cause for this failure mode could be allergic metal issue.The lot number is unknown therefore the device history record could not be reviewed.The instructions for use were found adequate and state the following: ¿b) stent -avoiding improper handling which may affect integrity of this device including bending, kinking or tearing - exercise caution to avoid damaging the stent with sharp instrumens.This may cause this device to tear, break or fragment.Determine proper stent length for the patient by a physicians.Selection of too short a stent may result in migration.The surture attached to the stent may be cut off prior to or after placement.Remove the surture before placing the stent in children.Any sign of infection in the location of the stent placement require removal of the stent.After checking the condition of the patient, a new stent should be placed.Care should be exercised when removing the stent to eliminate tearing or fragmentation.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® MULTILENGTH URETERAL STENT
Type of Device
STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
MDR Report Key9252222
MDR Text Key164240625
Report Number1018233-2019-06908
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
PMA/PMN Number
K043193
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Type of Report Initial,Followup
Report Date 11/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number788600
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/10/2019
Initial Date FDA Received10/29/2019
Supplement Dates Manufacturer Received11/04/2019
Supplement Dates FDA Received11/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age40 YR
-
-